BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 219 filers reported holding BLUEBIRD BIO INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,331,000 | -64.5% | 25,364 | -63.0% | 0.17% | -64.9% |
Q4 2017 | $12,197,000 | -40.0% | 68,485 | -53.7% | 0.48% | -42.7% |
Q3 2017 | $20,314,000 | +27.1% | 147,897 | -2.8% | 0.85% | +21.5% |
Q2 2017 | $15,986,000 | +321.7% | 152,174 | +264.9% | 0.70% | +302.9% |
Q1 2017 | $3,791,000 | -49.0% | 41,702 | -65.4% | 0.17% | -51.1% |
Q4 2016 | $7,439,000 | -66.1% | 120,572 | -62.8% | 0.35% | -68.3% |
Q3 2016 | $21,951,000 | +230.1% | 323,863 | +110.8% | 1.12% | +199.5% |
Q2 2016 | $6,650,000 | -26.2% | 153,610 | -27.6% | 0.37% | -26.3% |
Q1 2016 | $9,014,000 | -27.0% | 212,085 | +10.2% | 0.51% | -22.4% |
Q4 2015 | $12,354,000 | +177.3% | 192,375 | +269.4% | 0.65% | +123.3% |
Q3 2015 | $4,455,000 | -30.0% | 52,079 | +37.8% | 0.29% | -40.7% |
Q2 2015 | $6,362,000 | -20.0% | 37,784 | -36.9% | 0.49% | -24.5% |
Q1 2015 | $7,955,000 | -50.2% | 59,912 | -65.6% | 0.65% | -53.0% |
Q4 2014 | $15,966,000 | +86.1% | 174,070 | -27.2% | 1.39% | +68.6% |
Q3 2014 | $8,581,000 | – | 239,151 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |